Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
| Current Price | ₹1,416.10 |
|---|---|
| Market Cap | ₹1,429 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 34.6 |
| Return on Equity | 18.78% |
| 52-Week Range | ₹990.10 – ₹2,000.00 |
| Beta (1Y) | 0.06 |
1. Trading and Manufacturing of Pharmaceutical Products-100%
Beta Drugs Ltd is trading at ₹1,416.10, with a market capitalisation of ₹1,429 Cr.
Beta Drugs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Beta Drugs Ltd has a P/E of 34.6 and a return on equity of 18.78%.